Botox Rival Can Stay On Market Following Allergan Deal

By Britain Eakin · February 19, 2021, 5:36 PM EST

Evolus and Allergan announced a deal Friday that resolves trade secret theft allegations against Evolus, allowing Evolus' low-cost version of Allergan's Botox to stay on the market in the U.S. in...

To view the full article, register now.